ATCT-18 PHASE II STUDY OF MIPSAGARGIN (G-202), A PSMA-ACTIVATED PRODRUG TARGETING THE TUMOR ENDOTHELIUM, IN ADULT PATIENTS WITH RECURRENT OR PROGRESSIVE GLIOBLASTOMA

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Piccioni, David, Juarez, Tiffany, Brown, Bradley, Rose, Lara, Allgood, Victoria, Kesari, Santosh
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638569/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov206.18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars